Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular fate conversion via transcription factor programming refers to the process of inducing direct lineage conversion of cells by enforced expression of lineage-determining transcription factors. Rather than using extrinsic growth factors or morphogens, this approach employs specific combinations of transcription factors to activate a new transcriptional network in somatic cells, enabling efficient reprogramming into desired cell types such as neurons, cardiomyocytes, or hematopoietic stem cells. Advances have highlighted the potential for regenerative medicine, disease modeling, and cell therapy, but also underscored challenges such as incomplete conversion and safety risks. The phrase does not denote a discrete molecular target, but a suite of engineered approaches centered on transcriptional regulation to alter cell fate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular fate conversion via transcription factor programming.